The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?  

作　　者：Wen Liu Xuejing Yan Ruochuan Cheng 

机构地区：[1]Department of Thyroid Surgery,Clinical Research Center for Thyroid Diseases of Yunnan Province,The First Affiliated Hospital of Kunming Medical University,Kunming 650032,China [2]Department of Management of Chronic Non-communicable Diseases,Yunnan Center for Disease Control and Prevention,Kunming 650034,China

出　　处：《Cancer Biology & Medicine》2022年第5期619-634,共16页癌症生物学与医学（英文版）

基　　金：The work was supported by grants from the National Natural Science Foundation of China(Grant No.81760142);the Construction Project of Clinical Research Centre of General Surgical Disease in Yunnan Province(Grant No.2X2019-03-03);the“Ten Thousand People Plan”of Yunnan ProvinceMedical Experts Project(Grant No.RLCRC20210412).

摘　　要：Due to exponential increases in incidences,low risk papillary thyroid microcarcinoma(PTMC)has become a clinical and social issue in recent years.An active surveillance(AS)management approach is an alternative to immediate surgery for patients with low risk PTMC.With decreased doubts about the safety and validity due to evidence from a large number of studies,the AS approach has become increasingly popular worldwide.However,Chinese thyroid surgeons still lag behind other countries in their knowledge of clinical practices and research related to AS.To promote the implementation of AS in China,thyroid surgeons should understand the implications,advantages,and disadvantages of management approaches for AS,and should also consider the willingness of Chinese patients,the impact on the medical billing system,and the enthusiasm of doctors.Thus,a management approach for AS based on the Chinese population should be developed to reduce the risk of disease progression and enhance patient adherence.Herein,we summarize the recent research achievements and deficiencies in AS approaches,and describe the initial experiences regarding AS in the Chinese population,in order to assist Chinese thyroid surgeons in preparing for AS management in the era of PTMC precision medicine.

关 键 词：Papillary thyroid carcinoma MICROCARCINOMA active surveillance OBSERVATION 

分 类 号：R736.1[医药卫生—肿瘤]